Possibilities of the pharmacological correction of adaptive reactions of human organism in short-term moving from middle to high altitude]
Comparison in people · 2014
- What was studied
- Volunteers moving from 1,670 m to 3,750 m after 15 days at middle altitude
- Main finding
- An altitude-adaptation comparison reported earlier metabolic adaptation with combined Metaprot and Ladasten than with Hypoxen or placebo. The abstract does not quantify the work-capacity improvement.
Adaptation timing · Combination: within first hours; Hypoxen: by day 3; placebo: still developing on day 3 · Authors’ descriptive metabolic time course, not a timed endurance effect
Reported findings and study design
An altitude-adaptation comparison reported earlier metabolic adaptation with combined Metaprot and Ladasten than with Hypoxen or placebo. The abstract does not quantify the work-capacity improvement.
Volunteers acclimatized for 15 days at 1,670 m before moving to 3,750 m; group sizes not supplied.
Population or model Volunteers moving from 1,670 m to 3,750 m after 15 days at middle altitude
| Measure | Result | Comparison, timing and statistics |
|---|---|---|
| Adaptation timing | Combination: within first hours; Hypoxen: by day 3; placebo: still developing on day 3 | Authors’ descriptive metabolic time course, not a timed endurance effect |
| Exercise tolerance and blood-cell measures | Reported stronger responses with the combination | No absolute work or blood-cell effect sizes supplied |
| Studied arms | Metaprot 0.125 g + Ladasten 0.1 g; Hypoxen 0.5 g; placebo | Combination effect cannot be assigned to either component alone |
No component-only arms are described in the abstract. Earlier metabolic adaptation does not establish safe high-altitude use or independent bromantane efficacy.
Source for these results ↗ · Reviewed 2026-11-01
Study limitations and source details
Study limitations
- No single-component arms are described, so the study cannot isolate contributions or establish synergy.
- Enrollment and allocation details require full-text review.
- Not a validated altitude-illness prevention strategy.
Source details
Indexed citation and abstract checked through Europe PMC / PubMed. Original methods and risk of bias not fully appraised.
Sources checked
Citation
Kundashev UK, Zurdinov AZ, Barchukov VG. Possibilities of the pharmacological correction of adaptive reactions of human organism in short-term moving from middle to high altitude] Eksperimental'naia i klinicheskaia farmakologiia 77(9):32-37. PMID 25365868
Related compounds
Bemitil
A synthetic benzimidazole derivative also called bemethyl or Metaprot. Soviet and Russian researchers studied it as an actoprotector, a drug intended to preserve physical work capacity under stress.
Bromantane
A synthetic adamantane drug, also called Ladasten, studied in Russian fatigue and stress research.
Hypoxen / Olifen
Sodium polydihydroxyphenylene thiosulfonate, a synthetic sulfur-containing polymer formerly called Olifen. Researchers studied its effects under low-oxygen conditions.